Bioengineering

  1. Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response

    1. Qiu-Dong Su
    2. Ye-Ning Zou
    3. Yao Yi
    4. Li-Ping Shen
    5. Xiang-Zhong Ye
    6. Yang Zhang
    7. Hui Wang
    8. Hong Ke
    9. Jing-Dong Song
    10. Ke-Ping Hu
    11. Bo-Lin Cheng
    12. Feng Qiu
    13. Peng-Cheng Yu
    14. Wen-Ting Zhou
    15. Ran Zhao
    16. Lei Cao
    17. Gao-Feng Dong
    18. Sheng-Li Bi
    19. Gui-Zhen Wu
    20. George Fu Gao
    21. Jerry Zheng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Rapid generation of potent antibodies by autonomous hypermutation in yeast

    1. Alon Wellner
    2. Conor McMahon
    3. Morgan S. A. Gilman
    4. Jonathan R. Clements
    5. Sarah Clark
    6. Kianna M. Nguyen
    7. Ming H. Ho
    8. Vincent J. Hu
    9. Jung-Eun Shin
    10. Jared Feldman
    11. Blake M. Hauser
    12. Timothy M. Caradonna
    13. Laura M. Wingler
    14. Aaron G. Schmidt
    15. Debora S. Marks
    16. Jonathan Abraham
    17. Andrew C. Kruse
    18. Chang C. Liu

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  3. Hydrogel‐Based Slow Release of a Receptor‐Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS‐CoV‐2

    1. Emily C. Gale
    2. Abigail E. Powell
    3. Gillie A. Roth
    4. Emily L. Meany
    5. Jerry Yan
    6. Ben S. Ou
    7. Abigail K. Grosskopf
    8. Julia Adamska
    9. Vittoria C. T. M. Picece
    10. Andrea I. d'Aquino
    11. Bali Pulendran
    12. Peter S. Kim
    13. Eric A. Appel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery

    1. Alana Gerhardt
    2. Emily Voigt
    3. Michelle Archer
    4. Sierra Reed
    5. Elise Larson
    6. Neal Van Hoeven
    7. Ryan Kramer
    8. Christopher Fox
    9. Corey Casper

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered Komagataella phaffii

    1. Neil C. Dalvie
    2. Andrew M. Biedermann
    3. Sergio A. Rodriguez‐Aponte
    4. Christopher A. Naranjo
    5. Harish D. Rao
    6. Meghraj P. Rajurkar
    7. Rakesh R. Lothe
    8. Umesh S. Shaligram
    9. Ryan S. Johnston
    10. Laura E. Crowell
    11. Seraphin Castelino
    12. Mary K. Tracey
    13. Charles A. Whittaker
    14. J. Christopher Love

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers

    1. Saleh Riahi
    2. Jae Hyeon Lee
    3. Shuai Wei
    4. Robert Cost
    5. Alessandro Masiero
    6. Catherine Prades
    7. Reza Olfati-Saber
    8. Maria Wendt
    9. Anna Park
    10. Yu Qiu
    11. Yanfeng Zhou

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Multiple sites on SARS‐CoV ‐2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V

    1. Keval Bollavaram
    2. Tiffanie H. Leeman
    3. Maggie W. Lee
    4. Akhil Kulkarni
    5. Sophia G. Upshaw
    6. Jiabei Yang
    7. Hannah Song
    8. Manu O. Platt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Multi-modal engineering of Bst DNA polymerase for thermostability in ultra-fast LAMP reactions

    1. Inyup Paik
    2. Phuoc H. T. Ngo
    3. Raghav Shroff
    4. Andre C. Maranhao
    5. David J.F. Walker
    6. Sanchita Bhadra
    7. Andrew D. Ellington

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Peptide Antidotes to SARS-CoV-2 (COVID-19)

    1. Andre Watson
    2. Leonardo Ferreira
    3. Peter Hwang
    4. Jinbo Xu
    5. Robert Stroud

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  10. Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variants

    1. Emily Engelhart
    2. Randolph Lopez
    3. Ryan Emerson
    4. Charles Lin
    5. Colleen Shikany
    6. Daniel Guion
    7. Mary Kelley
    8. David Younger

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 21 of 26 Next